Cargando…

Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial

There is a real unmet need for primary biliary cholangitis (PBC) treatments that can improve quality of life impacting symptoms. In this post hoc analysis, we evaluated potential effects of the NADP oxidase 1/4 inhibitor, setanaxib, on patient-reported quality of life from a phase 2 trial in PBC. PA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, David, Carbone, Marco, Invernizzi, Pietro, Little, Nicola, Nevens, Frederik, Swain, Mark G., Wiesel, Philippe, Levy, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949832/ https://www.ncbi.nlm.nih.gov/pubmed/36809195 http://dx.doi.org/10.1097/HC9.0000000000000057

Ejemplares similares

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
por: Abenavoli, Ludovico, et al.
Publicado: (2020)

A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis
por: Manno, Valerio, et al.
Publicado: (2019)

Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
por: Sclair, Seth N, et al.
Publicado: (2015)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison
por: Montali, Lorenzo, et al.
Publicado: (2021)

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

Primary biliary cholangitis: Epidemiology, prognosis, and treatment
por: Trivella, Juan, et al.
Publicado: (2023)

LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
por: Overi, Diletta, et al.
Publicado: (2022)

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
por: Hirschfield, Gideon M., et al.
Publicado: (2023)

New insights on the role of human leukocyte antigen complex in primary biliary cholangitis
por: Mulinacci, Giacomo, et al.
Publicado: (2022)

Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis
por: Carbone, Marco, et al.
Publicado: (2018)

Comment on “Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis”
por: Cristoferi, Laura, et al.
Publicado: (2020)

A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale
por: Levy, Cynthia, et al.
Publicado: (2018)

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
por: Parés, Albert, et al.
Publicado: (2020)

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Reply to: “Ductular reaction is a prognostic factor in primary biliary cholangitis”
por: Carpino, Guido, et al.
Publicado: (2023)

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
por: Harms, Maren H, et al.
Publicado: (2020)

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis
por: Mayo, Marlyn J., et al.
Publicado: (2022)

Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?
por: Mulinacci, Giacomo, et al.
Publicado: (2021)

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis
por: Mayo, Marlyn J., et al.
Publicado: (2019)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis
por: Mayo, Marlyn J., et al.
Publicado: (2023)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis
por: Kowdley, Kris V., et al.
Publicado: (2023)

Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis
por: Medford, Abigail, et al.
Publicado: (2023)

Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence?
por: Lacetera, Rosanna, et al.
Publicado: (2022)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Real-world experience with obeticholic acid in patients with primary biliary cholangitis
por: D’Amato, Daphne, et al.
Publicado: (2021)

Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis
por: John, Binu V., et al.
Publicado: (2021)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis
por: Roberts, Surain B., et al.
Publicado: (2020)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_15b8s37htt3te8b422ns9pnfh8